"We would encourage you to visit www.coronavirus.gov for the latest information and guidance related to COVID-19"


Rino Rappuoli, Ph.D.

Scientific Director, Biotecnopolo di Siena Foundation, Italy

Paul Burton, MD Ph.D. FACC MRCS

Chief Medical Officer, Moderna

Walter Straus, MD, MPH, FACP

Vice-President, Clinical Safety, Moderna

Thomas Breuer, MD, MSc

Chief Global Health Officer, Global Health Management, GSK

Anuradha Gupta

President, Global Immunization, Sabin Vaccine Institute

Jay A. Berzofsky, MD.,Ph.D

Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

Alessandro Sette, Dr.Biol.Sci.

Professor, Center for Autoimmunity and Inflammation, Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology

Ofer Levy, MD, PhD

Staff Physician & Principal Investigator, Director, Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital Professor, Harvard Medical School

Hanneke Schuitemaker, PhD

VP, Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines and Prevention B.V.

Karin Bok, MS, PhD

Acting Deputy Director, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Mary Marovich, MD, FACP, DTMH

NIH, NIAID, Division of AIDS, Director, Vaccine Research Program

Swati Gupta, DrPH, MPH

VP, Emerging Infectious Diseases and Epidemiology, IAVI

Dan Barouch, M.D., Ph.D.

William Bosworth Castle Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard, Director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center

David B. Weiner, Ph.D.

Executive Vice President, The Wistar Institute, Director, Vaccine & Immunotherapy Center

Marco Pravetoni, Ph.D.

Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Director, Center for Medication Development for Substance Use Disorders and Overdose

Barbara A Jones, Ph.D.

IBM Quantum, IBM Research Almaden

Alexander Bukreyev, Ph.D.

Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, Galveston National Laboratory, University of Texas Medical Branch

Farshad Guirakhoo, Ph.D.

Chief Scientific Officer, ExpreS2ion Biotechnologies

Stephen L. Hoffman, M.D.

Chief Executive and Scientific Officer, Sanaria Inc.

Rama Rao Amara, Ph.D.

Charles Howard Candler Professor, Department of Microbiology and Immunology, Associate Director, Vaccine Development, Emory Vaccine Center, Co-Director, Developmental Core, Emory CFAR, Emory National Primate Research Center, Emory University

Robert O. Dillman, M.D.

Chief Medical Officer, AIVITA Biomedical, Inc., Clinical Professor of Medicine, UC Irvine

Magdalena Tary-Lehmann, M.D., Ph.D.

Chief Scientific Officer, Cellular Technology Limited, Adjunct Associate Professor of Pathology, Case Western Reserve University

John Shon, MD, MS

Chief Technology Officer, Serimmune

Shahin Gharakhanian, MD, DPH

Pharmaceutical Medicine, Infectious Diseases, Member, IDSA: Infectious Diseases Society of America. Shahin Gharakhanian MD Consulting LLC

Biao He, Ph.D.

President & CEO, CyanVac LLC

Christopher Rudd, PhD, DSc, FRSC

Professeur, Faculte de Medicine, Dept de microbiologie, infectiologie et immunologie, Director-Cell Signaling and Immunotherapy Section, Centre de Recherche Hopital Maisonneuve-Rosemont

Sriram Sathy, Ph.D.

Chief Scientific Officer, Codiak

Jonathan Lovell, Ph.D.

SUNY Empire Innovation Associate Professor, Department of Biomedical Engineering, Jacobs School of Medicine & Biomedical Sciences, University of Buffalo

Mark Connors, M.D.

Chief, HIV-Specific Immunity Section, NIAID/LIR

Jorge C. Blanco, Ph.D.

President and Scientific Director, Sigmovir Biosystems Inc.

About Organizer

Scientia Meetings understand the importance of networking and collaboration. Conferences are not just about discussion, but to sharing knowledge and research work, new ideas, and a lot of opportunities. We are launching events in the country to create real networking with scientists and researchers from research institutes, companies, laboratories, and government agencies. We aim to have our events with only a moderate number of invited guests/delegates attending related to discipline and to create a platform to have conversations leading to opportunities according to their respective needs. Our aim is to provide a platform for research scholars, scientific leaders, decision-makers to come together and share their research findings with the other scientific professionals which helps to improve the sharing of knowledge and easy access to scientific information.

We provide a unique opportunity to share your innovative ideas, evaluate your research works, and promote collaborative work through its networking sessions for a brighter future.